Botulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus Steroid
Not yet recruiting
Phase 2 Results N/ASummary of Purpose
The aim of this study is to confirm the efficacy and safety of the intra-articular injection of BT-A in a multicentric double blind randomised study. For this purpose intra-articular injection of BT-A will be compared with the intra-articular steroid injection that is the current "gold standard" for the treatment of HSP.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 14 November 2011.
1 Jan 2012 | 7 Nov 2011 | 1 Jun 2012 | 1 Jan 2013 | 1 Nov 2011 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- Giuseppe Galardi, Dr
View Trial Locations
Recruitment
- Enrollment: 52
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- Giuseppe Galardi, Dr
San Raffaele-Giglio Foundation